Lataa...
Dengvaxia: the world’s first vaccine for prevention of secondary dengue
The objective of this manuscript was to review and evaluate the efficacy and safety data of Dengvaxia for the treatment of severe secondary dengue infection. Dengvaxia is the brand name for chimeric yellow fever-dengue-tetravalent dengue vaccine (CYD-TDV). A literature search through PubMed was cond...
Tallennettuna:
| Julkaisussa: | Ther Adv Vaccines Immunother |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8132086/ https://ncbi.nlm.nih.gov/pubmed/34036241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/25151355211015839 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|